From: New discoveries on the biology and detection of human chorionic gonadotropin
Malignancy | Patients | Sensitivity (> 3 fmol/ml) |
---|---|---|
Healthy no history of malignancy | 97 | 9.3% |
Healthy benign disease | 159 | 6.9% |
TOTAL | 256 | 7.8% |
Ovarian cancer | 106 | 68% |
Cervical cancer | 89 | 46% |
Endometrial cancer | 110 | 51% |
Pancreatic cancer | 29 | 55% |
Bladder cancer | 102 | 48% |
Lung cancer | 122 | 24% |
TOTAL | 558 | 47% |